The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever

References

• Yilmaz R, Ozer S, Ozyurt H, Erkorkmaz U, Sahin S. Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children. J Paediatr Child Health. 2009;45:641–5.
   Google Scholar
• Gunel Ozcan A, Saym DB, Dibek Misirlioglu E, Guliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kinkkale University in Turkey. Mol Biol Rep. 2009;36:757–60.
   PubMed Web of Science ®Google Scholar
• Balci-Peynircioglu B, Waite AL, Hu C, Richards N, Staubach-Grosse A, Yilmaz E, et al. Pyrin, product of the MEFV locus, interacts with the proapoptotic protein, Siva. J Cell Physiol. 2008;216:595–602.
   Google Scholar
• Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N. Hyperco-agulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol. 2007;26:366–70.
   Google Scholar
• Dundar M, Emirogullari EF, Kiraz A, Taheri S, Baskol M. Common familial Mediterranean fever gene mutations in a Turkish cohort. Mol Biol Rep. 2011;38:5065–9.
   Google Scholar
• Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function pyrin mutations induce NLRP3 protein-inde-pendent interleukin-lbeta activation and severe autoinflammation in mice. Immunity. 2011;34:755–68.
   PubMed Web of Science ®Google Scholar
• Ozel Demiralp D, Ekim M, Akar N. The effect of plasminogen activator inhibitor-1-675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease. Clin Appl Thromb Hemost. 2009;15: 443–7.
   Google Scholar
• Manukyan GP, Ghazaryan KA, Ktsoyan ZhA, Tatyan MV, Khachatryan ZA, Hakobyan GS, et al. Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Bio-chem. 2008;41:920–2.
   PubMed Web of Science ®Google Scholar
• Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildirim G, et al. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. J Obstet Gynae-col Res. 2010;36:64–71.
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Carville KS, Abraham U. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcrip-tion. Mol Immunol. 1997;34: 391–9.
   Google Scholar
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–9.
   Google Scholar
• Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113:1596–606.
   PubMed Web of Science ®Google Scholar
• Gil W. Infiammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation. Perfusion. 2001;16:27–35.
   PubMed Web of Science ®Google Scholar
• Wingeyer SP, de Larranaga G, Cunto E, Fontana L, Nogueras C, San Juan J. Role of 4G/5G promoter polymorphism of plasmin-ogen activator inhibitor-1 (PAI-1) gene in outcome of sepsis. Thromb Res. 2010;125:367–9.
   PubMed Web of Science ®Google Scholar
• Emirogullari EF, Saatgi C, enal A, ahin A, Ozkul Y. Pro-thrombin, factor-V Leiden and plasminogen activator inhibitor type 1 gene polymorphisms in hemodialysis patients with/without arteriovenous fistula thrombosis. Int J Nephrol Urol. 2010; 2:314–9.
   Google Scholar
• Papadopoulos VP, Giaglis S, Mitroulis I, Riffs K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752–61.
   PubMed Web of Science ®Google Scholar
• Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003;22:99–101.
   PubMed Web of Science ®Google Scholar
• Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW. Endurance run increases circulating IL-6 and IL- lra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol. 1995;79:1497–503.
   Google Scholar
• Schattner A, Gurevitz A, Zemer D, Hahn T. Induced TNF pro-duction in vitro as a test for familial Mediterranean fever. Q J Med. 1996;89:205–10.
   Google Scholar
• Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid Al and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid. 2003;10:12–6.
   PubMed Web of Science ®Google Scholar
• Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr. 2003;45:198–202.
   PubMed Web of Science ®Google Scholar
• Karahan ZC, Ozturk A, Akar E, Akar N. Interleukin-6 (IL-6) — 174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis. J Nephrol. 2005;18:582–4.
   PubMed Web of Science ®Google Scholar
• Celebi Kobak A, Kobak S, Kabasakal Y, Akarca US. Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clin Rheumatol. 2007;26:908–910.
   PubMed Web of Science ®Google Scholar
• Li XX, Li N, Ban CJ, Zhu M, 'Ciao B, Dai HP. Idiopathic pul-monary fibrosis in relation to gene polymorphisms of trans-forming growth factor-betal and plasminogen activator inhibitor 1. Chin Med J. 2011;124: 1923–7.
   Google Scholar
• Lima LM, Carvalho MD, Fonseca Neto CP, Garcia JC, Sousa MO. PM-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease. Arq Bras Cardiol. 2011; 97:462–7.
   Google Scholar
• Sari I, Yuksel A, Kozaci D, et al. The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with FMF. Inflammation. 2012;35(3):1191–7.
   PubMed Web of Science ®Google Scholar